Skip to main content

Pfizer enlists children and adults for Lyme disease vaccine in a late stage clinical trial

On Monday, Pfizer and Valneva announced they will enlist 6,000 participants for a late-stage clinical trial of a Lyme disease vaccine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.